Back to Supplement Score

Topic hub

Everything you need to know about Vitamin D

Everything you need to know about vitamin D — the steroid hormone often mis-classified as a vitamin, with strong bone evidence and a complicated trial record on almost everything else.

Vitamin D status matters; routine high-dose supplementation in already-replete adults often does not. Form (D3 vs D2), dosing schedule (daily vs weekly vs bolus), and baseline 25-OH-D level decide most clinical outcomes.

The short version

TL;DR Who this matters for: people with documented 25-OH-D below 20-30 ng/mL, breastfed infants, older adults at fall risk, people with darker skin or limited sun exposure, and patients on glucocorticoids or with malabsorption (IBD, post-bariatric, cystic fibrosis).
What the evidence shows: Tier 1 evidence for treating documented deficiency, preventing rickets, and reducing fracture risk when combined with calcium in deficient older adults. Tier 2 / 3 for cancer mortality, respiratory infection, falls, and autoimmune outcomes — the VITAL extended follow-up is mixed. Bolus dosing (large monthly/quarterly doses) increased fractures and falls and should be avoided.
Top three picks: Vitamin D3 — the workhorse and best-studied form; Vitamin D3 liquid drops — for infants and dose precision; K2 + D3 combo — when calcium-traffic concerns drive the choice.

Vitamin D is the most-tested nutrient in primary care and the most-debated in the supplement world. The bone case is solid: combined with calcium, vitamin D reduces fragility fractures in deficient older adults, and exclusively or predominantly breastfed infants need supplementation from birth to prevent rickets. Beyond bone, the VITAL trial and its extended follow-ups have produced mixed signals on cancer mortality, cardiovascular events, fall prevention, and respiratory infection. Form and schedule matter — D3 raises 25-OH-D more reliably than D2, daily dosing outperforms weekly which outperforms bolus, and high single-dose schedules have actively increased fractures and falls in trials. Baseline 25-OH-D is the single biggest predictor of who will benefit: trials that enrolled already-replete adults found near-null results, while trials in deficient populations show robust effects. The smart frame is therefore "test, then treat to target", not "give everyone the same dose". SupplementScore tracks 4 distinct vitamin D supplements across 16 in-depth articles, 5 condition protocols, and 2 head-to-head comparisons. The pediatric guidance is especially important: breastfed infants need a daily drop from the first days of life, vitamin D drop dispensing errors are documented, and adolescents with low baseline have a small but consistent benefit on acne in IGF-1 and sebum trials.

Supplements in hub
4
Articles linked
16
Conditions
5
Comparisons
2

Top supplements in the vitamin d cluster

Each card shows the SupplementScore composite rating, evidence sub-scores, and a one-line summary. Click through for full dosing, timing, and safety detail.

Articles in this hub

In-depth explainers, breakthrough research updates, and myth checks — grouped by editorial category.

Conditions where vitamin d is part of the protocol

Head-to-head comparisons

Common questions

How much vitamin D should an adult take daily?

For adults with no documented deficiency, 1,000-2,000 IU/day of vitamin D3 is a defensible maintenance range, especially in winter or at higher latitudes. Adults with documented deficiency (25-OH-D below 20 ng/mL) usually need 4,000-5,000 IU/day for 8-12 weeks under monitoring, then a maintenance dose. Avoid bolus dosing schedules; the trial record there is unambiguously negative.

Is vitamin D3 better than vitamin D2?

D3 (cholecalciferol) raises and sustains 25-OH-D more reliably than D2 (ergocalciferol). D2 is the vegan/vegetarian option and is still effective, but typical doses must be roughly 2-3 times higher to match D3 outcomes. For non-vegans, D3 is the standard choice.

Do I need vitamin K2 alongside vitamin D?

For most people taking 1,000-2,000 IU/day of D3, a co-administered K2 is not clinically necessary. K2 may matter more at higher D3 doses (5,000+ IU/day chronically) or in people with calcification concerns. The strongest K2 trials use MK-7 at 90-180 mcg/day. If in doubt, take K2 from food (natto, hard cheeses, egg yolks) rather than escalating doses on the supplement side.

Should breastfed babies take vitamin D drops?

Yes. The American Academy of Pediatrics recommends 400 IU/day from the first few days of life through the first year, because human breast milk does not contain enough vitamin D to prevent rickets in exclusively or predominantly breastfed infants. Drops should be precisely measured — overdose cases from concentrated formulations are documented.

Does vitamin D really prevent falls or fractures?

When combined with calcium in older adults with low baseline 25-OH-D, yes — vitamin D reduces fracture risk modestly. In replete adults the trial record is much weaker, and high-dose bolus schedules have actually increased falls and fractures. The story is: replete the deficient, do not over-treat the rest.

Should I get my vitamin D level tested?

Routine testing in healthy adults is not recommended by most professional bodies and is rarely covered by insurance. Testing makes the most sense if you have a known risk factor: dark skin, limited sun exposure, malabsorption, glucocorticoid use, post-bariatric surgery, chronic kidney disease, osteoporosis, or unexplained musculoskeletal pain. The target is generally a 25-OH-D level of 30-50 ng/mL (75-125 nmol/L); pushing above 50 ng/mL with supplements has no documented benefit and crosses into the toxicity gradient.

Can vitamin D be toxic?

Yes, but it takes either chronic very-high dosing (typically 50,000+ IU/day for months) or accidental concentrated-drop overdoses in infants. Vitamin D toxicity raises calcium, causes nausea, kidney stones, and in extreme cases cardiac arrhythmia. The IOM upper limit for adults is 4,000 IU/day. Stay below that without a clinician-supervised reason to exceed it, and avoid the concentrated infant-drop formulations where a small measurement error becomes a hospital visit.

Evidence sources

  1. PMID 38447020 — LeBoff MS et al. 2024 — VITAL extended-follow-up cancer mortality.
  2. PMID 30415629 — Manson JE et al. 2019 — VITAL primary results (cancer/CVD).
  3. PMID 30575485 — Bischoff-Ferrari HA et al. 2018 — Vitamin D and fall prevention.
  4. PMID 20460620 — Sanders KM et al. 2010 — Annual high-dose vitamin D and fractures/falls (bolus harm).
  5. PMID 21646368 — Holick MF et al. 2011 — Endocrine Society vitamin D guideline.
  6. PMID 27484065 — Tripkovic L et al. 2017 — D3 vs D2 head-to-head review.
  7. PMID 22552031 — Wagner CL et al. 2008 — AAP rationale for infant 400 IU/day.
  8. PMID 33077577 — Martineau AR et al. 2019 — Vitamin D and acute respiratory infection meta-analysis.
  9. PMID 32652515 — LeBlanc ES et al. 2020 — Vitamin D and falls in older adults (STURDY).
Educational reference, not medical advice. Last reviewed 2026-05-21. About · Privacy · Terms